Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Licenses IP from Erasmus Medical Center

NEW YORK (GenomeWeb News) – Bruker today announced it has licensed intellectual property from the Erasmus Medical Center for the rapid testing of beta-lactamase activity using MALDI-TOF technology.

The method being licensed is compatible with the Bruker MALDI Biotyper system, which uses MALDI-TOF mass spectrometry for identifying microorganisms, the company said.

Extended-spectrum beta-lactamase is a mechanism of antibiotic resistance, in which enzymes produced by bacteria attack and cleave the beta-lactam ring in antibiotics. MALDI-TOF MS can provide an exact determination of the molecular weight of a broad range of antibiotics, Bruker said, and its MALDI Biotyper can measure the molecular weights of antibiotics which have been converted into fragments in the presence of extended-spectrum beta-lactamase.

The instrument, Bruker added, can provide shorter time-to-result and potentially better specificity than with traditional biochemical testing.

"While MALDI Biotyper-based microbial identification is already established in many countries, we see significant growth potential in MALDI-based beta-lactamase testing," Wolfgang Pusch, executive vice president of the microbiology business at Bruker Daltonics, said in a statement. "The exclusively licensed IP from Erasmus Medical Center further strengthens our own broad portfolio of intellectual property in the field of mass spectrometry-based microbial analysis ranging from sample preparation, data processing, MALDI-TOF technology, direct analysis from positive blood cultures and beta-lactamase testing, and offers laboratories worldwide another tool in the fight against resistant bacteria."

Financial and other terms of the deal were not disclosed.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.